Private biopharmaceuticals company pioneering the discovery of novel drugs using its expertise in Transient Receptor Protocols in ion channels and molecular regeneration
- Year invested 2002
- Investment Stage Early
- Sectors
- Investment Status Current
- Website hydrabiosciences.com/
- Company Status Private